These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6815107)

  • 1. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
    Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with danazol treatment of endometriosis and mastopathy].
    Pavelka R; Schneider WH
    Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins.
    Rose DP; Boyar AP; Cohen C; Strong LE
    J Natl Cancer Inst; 1987 Apr; 78(4):623-6. PubMed ID: 3104646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF; de Freitas MM; Velludo MA
    Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
    Baranowska B; Stopińska-Głuszak U
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of benign breast disease with bromocriptine.
    Mussa A; Dogliotti L
    J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bromocriptine in fibro-cystic mastopathy].
    Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
    Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
    [No Abstract]   [Full Text] [Related]  

  • 14. Benign breast disease.
    Mauvais-Jarvis P; Kuttenn F
    Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
    [No Abstract]   [Full Text] [Related]  

  • 15. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K; Stanosz S
    Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
    Sokolova ZP
    Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of benign breast pathology with bromocriptine].
    Tolino A; Cardone A; Mastrantonio P; Chiacchio G
    Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of premenstrual tension syndrome with bromocriptine.
    Andersch B; Hahn L; Wendestam C; Ohman R; Abrahamsson L
    Acta Endocrinol Suppl (Copenh); 1978; 216():165-74. PubMed ID: 347860
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy].
    Ablanedo J; Canales ES
    Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.